Top Markets
#1 Zora Zora +42.47%
#2 AI XOVIA AI XOVIA +37.42%
#3 0G 0G +21.07%
#4 Full Moon Full Moon +19.35%
#5 Axelar Axelar +14.32%
#6 Notcoin Notcoin +13.85%
#7 Wrapped NXM Wrapped NXM +12.92%
#8 ZKsync ZKsync +12.68%
#9 rsERG rsERG +12.06%
#10 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +10.43%
Coin of the day
Zora Zora
Ayarlar
Dil
TüRKçE
Para birimi
USD
Tema
Eikon Therapeutics, Inc. Common Stock Eikon Therapeutics, Inc. Common Stock

Eikon Therapeutics, Inc. Common Stock

EIKN
Hisse Senetlerindeki Sıralama #12325
Eikon Therapeutics, Inc. is a clinical biopharmaceutical company, established... Eikon Therapeutics, Inc. is a clinical biopharmaceutical company, established in 2019 and headquartered in Millbrae, California, operating within the United States. The company is dedicated to developing groundbreaking medicines to address significant unmet medical needs. It utilizes a proprietary platform capable of precisely characterizing protein interactions inside living cells. Eikon's drug pipeline includes EIK1001, a systemically delivered TLR 7/8 dual-agonist designed to activate both innate and adaptive anti-cancer immune responses; EIK1003 and EIK1004, which are selective PARP1 inhibitors for ovarian, breast, prostate, and pancreatic cancers. Notably, EIK1004 is brain-penetrant, offering a therapeutic approach for brain metastases and primary brain malignancies. Additionally, EIK1005 is a potent WRN helicase inhibitor and anti-tumor agent aimed at MSI-high tumors, alongside EIK1006.
Hisse Fiyatı
$11.03
Son senkronizasyon: 2026-08-28
Piyasa Değeri
$597.15M
Değişim (1 gün)
-4.25%
Değişim (1 yıl)
-
Ülke
US
Ticaret Eikon Therapeutics, Inc. Common Stock (EIKN)

Kategori

Healthcare
Eikon Therapeutics, Inc. Common Stock (EIKN) için kazanç
2026 itibarıyla kazanç TTM: 0
Eikon Therapeutics, Inc. Common Stock şirketinin en son finansal raporlarına göre, mevcut kazancı 0'dir. 2026 yılında şirket 0 kazanç elde etti, bu 2026 yılındaki 0 kazanca göre önceki yıla eşit. Bu sayfada gösterilen kazanç, faiz ve vergiler öncesi kazançtır; yani EBIT.
Eikon Therapeutics, Inc. Common Stock için kazanç geçmişi 2026 - 2026
Her yılın sonundaki kazanç
Yıl Kazanç Değiştir
Sağlanan tarihler için yeterli veri yok.
Benzer şirketler veya rakipler için kazanç
Şirket Kazanç Kazanç Farkı Ülke
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH